Crossmark

A high adalimumab induction dosing regimen achieves clinical and endoscopic remission in super-refractory ulcerative colitis

Crossref DOI link: https://doi.org/10.1016/j.gastre.2022.02.007

Published Print: 2022-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ruiz-Cerulla, Alexandra

Rodríguez-Alonso, Lorena

Rodríguez-Moranta, Francisco

Guardiola, Jordi
License Information

Text and Data Mining valid from 2022-12-01

stm-asf valid from 2022-12-01

stm-asf valid from 2022-12-01

stm-asf valid from 2022-12-01

stm-asf valid from 2022-12-01

stm-asf valid from 2022-12-01
More Information

This article is maintained by: Elsevier

Article Title: A high adalimumab induction dosing regimen achieves clinical and endoscopic remission in super-refractory ulcerative colitis

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2022.02.007

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.